Could Your Phase II Or Phase III Clinical Trial Benefit From A Special Protocol Assessment (SPA)?
Source: Rho
Special Protocol Assessments (SPA) are an opportunity to get upfront input and buy-in from FDA on the scientific, regulatory, and statistical rigor of your planned adequate and well controlled clinical trial. SPAs can be done for clinical protocols, non-clinical carcinogenicity protocols, and CMC stability protocols.
In the case of clinical protocols, an SPA is highly advisable for any phase III clinical trial and for phase II clinical trials for programs seeking accelerated approval. The SPA will give you an opportunity to finalize not only the protocol but case report forms and the statistical analysis plan as well.
access the White Paper!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more